Search

Search Constraints

You searched for: Author/Creator Hosaka, Tetsuya

Search Results

21. Evolution of simeprevir‐resistant variants in virological non‐responders infected with HCV genotype 1b. Issue 4 (April 2015)

22. Evolution of simeprevir‐resistant variants over time by ultra‐deep sequencing in HCV genotype 1b. Issue 8 (5th May 2014)

23. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon‐alpha‐2b and ribavirin in hepatitis C patients. Issue 7 (29th November 2012)

24. Factors associated with the effect of interferon‐α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B. Issue 12 (4th February 2015)

25. Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older. Issue 1 (8th June 2016)

26. Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct‐acting antivirals regimens. Issue 1 (3rd September 2018)

27. Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study. Issue 9 (17th May 2022)

28. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. (August 2020)

29. Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase. (16th May 2022)

30. Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. (December 2020)